5 Minutes with Maria Gonzalez
20 May 2016
This International Clinical Trials Day (20th May) we reflect on the importance of clinical trials and the people who dedicate their lives to helping melanoma patients today and in the future. We've sat down with MIA's Clinical Trials Manager, Maria Gonzalez to discuss.
What does a Clinical Trials Manager do and how did you get here?
In my role I work with a team of highly dedicated and caring trial co-ordinators who are responsible for looking after our trial patients. I completed a degree in nursing at The University of Sydney and worked at Royal Prince Alfred Hospital before deciding to work in clinical trials in the hope that I may contribute to life-saving research. I have been at MIA for 6 years now.
What are clinical trials so important?
Clinical trials provide patients with access to unavailable new treatments and are also the vital step in making discoveries that will enable us to find a cure for melanoma. Clinical trials are also an opportunity for patients to receive very specialised care from clinical trial co-ordinators who are available at every step along the way to support patients and their families.
What do you find most rewarding about your work?
As a nurse I am most rewarded by making a difference in the lives of those suffering with cancer. It is a privilege to be part of a patient support network at MIA and also wonderful to share in the good news when a trial treatment is successful. Although we have made significant progress and the future is positive, it is important we keep working together to find the cure.
Congratulations to PhD Student, Tuba Nur Gide who was awarded a NSW National Council of Women Australia Day Award for her PhD research work.
Melanoma Institute Australia, is joining forces with the Wollongong Wolves Football Club in the battle to reduce Australia’s melanoma rates.
A new research project will evaluate the benefits and economic implications of CT and PET/CT imaging in patients with asymptomatic Stage III melanoma.
Sunscreen tips for a skin smart summer with the help of Professor Pascale Guitera, Dermatologist Associate for Melanoma Institute Australia.
Although survival rates for people with skin melanoma are increasing, these promises of hope are not being seen in uveal melanoma. Researchers are desperately trying to uncover new ways to treat this disease.
Lucinda Ryan and Carole Renouf talking about melanoma preventation and awareness on 720 ABC Perth.
Research projects led by MIA have been awarded almost $6 million in the latest NHMRC funding round which will enable vital progression of research into melanoma prevention and treatment.
The last decade has seen a surge in therapeutic options for advanced melanoma patients, thanks to research. However, not every patient responds to treatment and researchers are taking on the challenge to find out why.
Our first Global Melanoma Research Report shares selected research from around the world and here at MIA that is making a difference to the lives of melanoma patients now and in the future.
After 18 years as Director of the Sydney Melanoma Unit and then Executive Director of Melanoma Institute Australia, Professor John Thompson AO will step down from the position at the end of 2016.
Australian melanoma clinical practice guidelines have been published on a wiki platform for the first time as researchers try to keep up to date with emerging evidence.
Carole Renouf, CEO of Melanoma Institute Australia is asking young Australians who have been affected by melanoma to share their experiences with her.
Melanoma Institute Australia CEO Carole Renouf wants to make sure Aussies remember to take care of our skin as the festive season draws closer and we spend more time in the sun.
Can an individual’s risk factors for melanoma be used to tailor skin self-examinations and surveillance programs?
Prof Georgina Long has been appointed President-Elect Society for Melanoma Research (SMR).
The Australasian Melanoma Conference is bringing together some of the world's leading researchers and clinicians.
Best practice guidelines for melanoma care have gone digital with the first-ever online guidelines developed to adapt to the rapid change in clinical management.
Congratulations are in order for two of our talented researchers.
Professor Richard Scolyer will be sharing his expertise on melanoma pathology at the upcoming Australasian Melanoma Conference. Here he discusses what he'll be presenting on.
Researchers at MIA have established a High Risk Clinic to monitor people at very high risk of developing melanoma.